{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:17:14Z","timestamp":1778527034217,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011797","name":"Turun Yliopistollinen Keskussairaala","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.amjcard.2019.08.050","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T16:09:14Z","timestamp":1569514154000},"page":"1894-1899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure"],"prefix":"10.1016","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-4344","authenticated-orcid":false,"given":"Jussi-Pekka","family":"Pouru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5944-6814","authenticated-orcid":false,"given":"Samuli","family":"Jaakkola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Biancari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Saraste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0193-568X","authenticated-orcid":false,"given":"K.E. Juhani","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.08.050_bib0001","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0002","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0003","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1474-4422(12)70042-X","article-title":"Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF","volume":"11","author":"Hankey","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004517","article-title":"Major bleeding complications and persistence with oral anticoagulation in non-valvular atrial fibrillation: contemporary findings in real-life Danish patients","volume":"6","author":"Lamberts","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0006","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF Trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0007","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.thromres.2011.05.021","article-title":"Safety of coronary artery bypass surgery during therapeutic oral anticoagulation","volume":"128","author":"Airaksinen","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0008","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2013.04.089","article-title":"Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study","volume":"62","author":"Airaksinen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0009","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.ijcard.2013.06.022","article-title":"Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment \u2014 the FinPAC study","volume":"168","author":"Airaksinen","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0010","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.amjcard.2014.03.038","article-title":"Performance of bleeding risk-prediction scores in patients with atrial fibrillation undergoing percutaneous coronary intervention","volume":"113","author":"Kiviniemi","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0011","first-page":"4","article-title":"Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies","volume":"19","author":"Tzikas","year":"2017","journal-title":"EP Eur"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0012","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0013","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/j.thromres.2012.05.013","article-title":"Percutaneous left atrial appendage closure with minimal antithrombotic treatment in patients at very high risk of bleeding events","volume":"130","author":"Lund","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0014","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182,678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0015","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0016","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijcard.2016.06.041","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy the PREVAIL trial","volume":"219","author":"Belgaid","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0017","first-page":"1397","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion","volume":"16","author":"Meier","year":"2014","journal-title":"EP Eur"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0018","first-page":"68","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"90","year":"2009","journal-title":"Aust J Pharm"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0019","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/ene.13280","article-title":"Stroke recurrence in patients with atrial fibrillation: concomitant carotid artery stenosis doubles the risk","volume":"24","author":"Lehtola","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0020","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.jacc.2016.08.016","article-title":"Single antiplatelet therapy following left atrial appendage closure in patients with contraindication to anticoagulation","volume":"68","author":"Rodriguez-Gabella","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0021","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.acvd.2016.09.006","article-title":"Percutaneous left atrial appendage closure followed by single antiplatelet therapy: short- and mid-term outcomes","volume":"110","author":"Jalal","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0022","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.4244\/EIJ-D-16-00726","article-title":"Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy","volume":"12","author":"Korsholm","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0023","first-page":"449","article-title":"Long-term event reduction after left atrial appendage closure. Results of the Iberian Registry II","author":"L\u00f3pez-M\u00ednguez","year":"2018","journal-title":"Revista Espanola de Cardiologia"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0024","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0025","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.4244\/EIJ-D-18-00344","article-title":"Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry","volume":"14","author":"Landmesser","year":"2018","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2019.08.050_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006841","article-title":"Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology","volume":"12","author":"Boersma","year":"2019","journal-title":"Circ Arrhythmia Electrophysiol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919310458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919310458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:04:57Z","timestamp":1762077897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919310458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0002914919310458"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.08.050","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.08.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}